Case Studies

Pharma and Biotech

Boosting Claims for a Health Product Launch 

Read the case study and learn how a major healthcare company successfully optimized their product launch and boosted claims to make it more compelling to consumers. Objective A major healthcare company wanted to validate its regulatory strategy...

Read more

Pharma and Biotech

Driving Pharmaceutical Regulatory Intelligence for Better Decision Making

Results The company gained increased visibility into the regulatory landscape impacting their product categories, along with enhanced agility and confidence in risk management and decision-making processes based on industry trends and foresight. Book a demo to learn...

Read more

Pharma and Biotech

Anticipating Regulatory Risks and Opportunities in Consumer Health Industry

How to detect emerging regulatory risks and opportunities and stay ahead of the market in the consumer health industry? Read our case study to learn more.  Objective A leading natural health and dietary supplements company wanted to...

Read more

Pharma and Biotech

Decentralized Clinical Trials: How CROs Can Benefit from RegASK Solutions

As the COVID-19 pandemic continues to disrupt clinical research, there is an increased need from the pharmaceutical and CRO industry to implement decentralized or hybrid clinical trials (DCTs) for improving clinical trial efficiency. Read our case study...

Read more

Pharma and Biotech

How Real-World Evidence Supported Claim Substantiation on OTC Product in Europe and the USA

A leader in the pharmaceutical industry wanted to leverage real-world evidence to bolster the claims of an over the counter (OTC) product in the E.U. and U.S. markets. Indeed, as researchers collect real-world evidence, they can examine...

Read more

Pharma and Biotech

Market Entry to Mexico for a Health Product

  Demand: Evaluating the Likelihood of Product Certification in the Mexican Market A large Chinese health-products company sought expansion into the Mexican market. The company requested RegASK’s assistance in determining the feasibility of gaining market entry into...

Read more